Molecular Targets and Cancer Therapeutics 

Research in the Molecular Targets and Cancer Therapeutics theme focuses on developing new approaches to treat the most aggressive forms of childhood brain cancer, leukaemia , and neuroblastoma.

Our broad aim is to develop targeted therapies for childhood cancer that are not only more effective than current therapies but also safer to use in children, causing fewer side effects.

Our approach involves:

• Identifying and validating new molecular targets.
  
  
• Discovering and optimising new drugs or combinations.
  
  
• Developing realistic pre-clinical systems to model clinical activity.
  
  
• Ultimately establishing clinical trials to test new targeted therapies.

Research groups

News & blogs